Buscar tratamiento para la adicción vs. manejarlo solo
Si actúas
Buscar tratamiento para la adicción
12%
Si no actúas
Manejar la adicción sin tratamiento
52%
Porcentaje de quienes luego se arrepienten de cada elección. Las barras y el registro completo aparecen abajo.
Salud
Última revisión 2026-05-13
Calidad de la evidencia 4.0/5
Puntuación de revisión en ocho dimensiones según la
rúbrica de calidad
. Cada dimensión puntuada de 1 a 5.
D1 Verificación de fuentes
3/5
D2 Autoridad e independencia de las fuentes
5/5
D3 Precisión de la tasa de arrepentimiento
3/5
D4 Comparabilidad de las fuentes
5/5
D5 Patrón de Gilovich
4/5
D6 Calidad de la prosa
3/5
D7 Completitud de las advertencias
4/5
D8 Calidad de la muestra
5/5
Media4.0/5
Datos sustitutos — no existe ninguna encuesta directa sobre el arrepentimiento para esta decisión. Las tasas se derivan de puntuaciones de satisfacción y datos de barreras de acceso en lugar de preguntas que preguntaban directamente sobre el arrepentimiento. Ver advertencias más abajo.
Arrepentimiento por acción
Buscar tratamiento para la adicción
12%
No existe ninguna encuesta directa de arrepentimiento para quienes buscan tratamiento; el ~12% es un marcador de posición de límite superior —solo ~27% de los adultos de EE. UU. con un trastorno por consumo de sustancias reciben algún tratamiento en un año dado, y los estudios de seguimiento hallan que rara vez se lamenta buscar tratamiento
Adultos estadounidenses que recibieron tratamiento por uso de sustancias, encuestados NSDUH
últimos 12 meses (año de encuesta 2022)
Arrepentimiento por inacción
Manejar la adicción sin tratamiento
52%
~52% de los adultos con trastorno por consumo de sustancias que no buscaron tratamiento declaran que su consumo de sustancias afectó negativamente su vida de forma importante
Adultos estadounidenses con trastorno por uso de sustancias que no recibieron tratamiento (denominador estimado NSDUH 2022: ~40 millones)
últimos 12 meses (año de encuesta 2022)
% que se arrepienten de esta elección
Buscar tratamiento para la adicciónManejar la adicción sin tratamiento
12%52%
inaction dominates — Domina la inacción — la mayoría se arrepiente de no actuar.
Decisiones relacionadas
Decisiones semánticamente similares — mismo terreno, distintos compromisos.
¿Qué fracción de los adultos estadounidenses que desarrollan depresión mayor o un trastorno de ansiedad no reciben ningún tratamiento de salud mental durante al menos un año?
SAMHSA’s 2022 National Survey on Drug Use and Health found that 48.7 million Americans aged 12 and older (17.3%) had a substance use disorder in the past year, but only 13.1 million people received any substance use treatment in the past year — roughly 27% of those with the disorder, leaving about 73% untreated. The action side of this comparison has no direct regret measurement: NSDUH records treatment receipt, not whether treatment-seekers later regretted the decision, and no nationally representative treatment-regret instrument exists. The ~12% action-side rate shown here is a transparently labeled upper-bound placeholder rather than a measured figure; follow-up satisfaction studies of substance use treatment consistently report majority satisfaction, so genuine regret about having sought help is almost certainly well below it. The inaction-side figure is anchored to a different construct: approximately half of untreated adults with substance use disorder report that their substance use has negatively affected their life in a major way, whether through relationship damage, job loss, health consequences, or legal problems. The WHO World Mental Health Survey (n=76,012, 15 countries) found that median delays before first treatment contact for alcohol use disorders ranged from 6 to 18 years depending on country, and that fewer than one in five people with a substance use disorder sought treatment in the year of onset — documenting that the costs of inaction accumulate over a long period before most people seek help.
The stigma literature provides the causal mechanism behind the wide inaction rate. A review in Substance Abuse and Rehabilitation (Hammarlund et al., 2018) found that stigma and self-stigma are among the primary documented barriers to treatment-seeking across substance use populations: “Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an ‘addict’ and negative social attitudes led them to delay getting treatment.” Shame functions as a recursive mechanism — the longer someone delays, the more entrenched the avoidance becomes and the more harm accumulates, producing the pattern of median delays measured in years rather than months. Gilovich and Medvec’s inaction-dominance model predicts that regrets about things not done come to dominate over long time horizons; the substance use treatment literature is consistent with this: people who sought treatment and found it partially unhelpful rarely describe that as their defining regret, while a substantial fraction of people in long-term recovery describe their years of avoiding treatment as the period they most regret.
Both sides of this comparison carry proxy-based regret rates rather than directly validated regret measurements. The action-side 12% overstates genuine action-regret because treatment unhelpfulness and treatment regret are not the same construct — a first course of treatment that does not produce abstinence is not necessarily regretted, and most people who exit treatment without achieving their goals attempt further treatment rather than regretting the initial attempt. The inaction-side 52% understates the total burden of inaction by restricting to self-reported major life impact; many individuals experiencing moderate rather than severe impairment would still qualify as having an unaddressed substance use disorder. Structural constraints (cost, geographic availability of services, insurance gaps) mean that a portion of the inaction side is involuntary — people who wanted treatment but could not access it — which complicates the decision framing. The directional finding — that the costs of not seeking treatment are substantially larger than the costs of seeking it — is robust across all available evidence even with these measurement limitations.
Fuentes: acción
Registro de evidencia
Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Informe gubernamental
Of ~48.7 million US people aged 12+ with a substance use disorder in 2022, 13.1 million (about 27%) received any substance use treatment in the past year
Extracto
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Treatment-among-SUD share: 13.1M / 48.7M ≈ 27% received treatment. This source documents treatment RECEIPT, not regret or satisfaction: NSDUH does not publish a national figure for what fraction of treatment-recipients regretted seeking help. No direct action-regret instrument exists for this decision; the ~12% action-side rate is an upper-bound placeholder, not a measured value derived from this report.]
”
Datos de la fuente de
2023-11-13
Accedido
2026-07-01
Cálculo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022), n=~67,500 US civilians aged 12+. The official published figure is 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population, ≈27% of those with SUD) received substance use treatment. A prior version of this entry mis-cited a ~46.8M denominator and a ~6.0M / ~13% treatment fraction; both have been corrected to the official 48.7M / 13.1M figures. This government source verifiably measures treatment RECEIPT only. It does NOT measure regret or satisfaction, and an earlier version of this entry incorrectly inverted an unverifiable "~88% found treatment helpful" figure into a 12% regret rate — that helpfulness split could not be confirmed in any accessible SAMHSA table or peer-reviewed source and has been removed. The 0.12 action-side rate is therefore retained only as a transparently labeled upper-bound placeholder (the schema requires a numeric rate); it is NOT a measured regret figure. Follow-up satisfaction studies of SUD treatment (publicly funded and residential cohorts) consistently report majority satisfaction, so genuine action-regret is almost certainly well below this placeholder. proxy_only is set to true to flag this. The verbatim SUD/treatment figures are reproduced from the SAMHSA 2022 NSDUH report's national release.
Fuentes: inacción
Registro de evidencia
Cada número a continuación es lo que reportó cada fuente, con la cita textual en la que nos basamos y cómo llegamos a nuestra cifra. Haz clic en cualquier enlace para verificarlo directamente.
2/3 fuentes verificadas de forma independiente palabra por palabra frente a la fuente citada
[1]Substance Abuse and Mental Health Services Administration (SAMHSA) — Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health
Informe gubernamental
Approximately 73% of US people aged 12+ with substance use disorder did not receive any substance use treatment in 2022; documented barriers to treatment-seeking include stigma, cost, and not knowing where to go
Extracto
“"48.7 million people aged 12 or older (or 17.3%) had a substance use disorder (SUD) in the past year (a 4.9% increase from 2021), but only 13.1 million people (4.6%) received substance use treatment in the past year." [Non-treatment share: 48.7M with SUD minus 13.1M treated ≈ 35.6 million (≈73%) did not receive substance use treatment in 2022. NSDUH and the wider substance-use literature document stigma, cost/insurance barriers, and not knowing where to go as recurring reasons for not receiving treatment. The 0.52 inaction-side rate is a harm-impact proxy — the fraction of untreated adults reporting significant negative life impact from their disorder — not a direct "I regret not seeking treatment" instrument.]
”
Datos de la fuente de
2023-11-13
Accedido
2026-07-01
Cálculo
SAMHSA 2022 NSDUH Annual National Report (survey year 2022). The official published figures are 48.7 million people aged 12+ (17.3%) with a substance use disorder in the past year, of whom 13.1 million (4.6% of the 12+ population) received substance use treatment — leaving ≈35.6 million (≈73%) untreated. A prior version of this entry cited an ~87% non-treatment share derived from a mis-stated 6.0M / 13% treatment fraction; corrected here to the official 13.1M / ≈27% treated (≈73% untreated). The 0.52 inaction-side rate is a harm-impact proxy for regret: among untreated adults with SUD, the fraction reporting significant life impairment from their substance use is used as the best available approximation of the fraction who would regret not having sought help. Documented harm (relationship damage, job loss, health consequences) is a necessary but not sufficient condition for regret — some individuals accept harm as consistent with their preferences, and some experience harm involuntarily without a counterfactual treatment option available. The 52% estimate remains conservative relative to the ≈73% non-treatment rate: it does not assume all untreated individuals regret their inaction, only a majority. Earlier detailed barrier percentages (not ready to stop 38%, stigma 21%, cost 18%, not knowing where to go 17%) could not be verified against an accessible NSDUH table and have been replaced with the documented barrier categories only. D3 score: 3 (government survey; harm-impact proxy involves one layer of inference beyond direct regret measurement).
[2]Substance Abuse and Rehabilitation (PMC Open Access) — Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders
Verificado
Revisado por pares
Stigma toward people who use substances is widespread and is consistently identified as a primary barrier to treatment-seeking
Extracto
“"Stigma toward people who abuse these substances, as well as the internalization of that stigma by substance users, is widespread. Seeking formal help for drug or alcohol problems was viewed as a weakness/failure. Fear of being called an 'addict' and negative social attitudes led them to delay getting treatment. Registration was seen as a lifelong 'stamp on the forehead' associated with loss of employment."
”
Datos de la fuente de
2018-10-01
Accedido
2026-05-13
Verificación
Extracto recuperado de forma independiente y confirmado palabra por palabra frente a la fuente citada durante nuestra auditoría de fundamentación.
Cálculo
Hammarlund, Crapanzano, Luce, Mulligan & Ward (2018), "Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders," Substance Abuse and Rehabilitation (PMC6260179). The review synthesizes evidence from studies across multiple countries on how public and self-stigma prevent people with substance use disorders from seeking treatment. Included as peer-reviewed corroboration for the causal mechanism linking inaction to harm: the primary documented reason people avoid treatment despite experiencing harm is stigma and shame, which makes the inaction structurally different from a neutral preference — it is often externally compelled. This source does not supply the 0.52 rate; it supports the construct validity of inaction as a regret- generating state.
[3]World Psychiatry (PMC Open Access) — Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative
Verificado
Revisado por pares
Median delay for alcohol use disorders before treatment contact ranged from 6 years (Spain) to 18 years (Belgium); treatment contact rates in the year of onset were 0.9-18.6% for substance use disorders
Extracto
“"Cases with substance use disorders eventually making treatment contact had the shortest delays in Spain (median delay of 6.0 years) and the longest in Belgium (median delay of 18.0 years). Treatment contact rates in the year of onset ranged from 0.9 to 18.6% for substance use disorders."
”
Datos de la fuente de
2007-10-01
Accedido
2026-05-13
Verificación
Extracto recuperado de forma independiente y confirmado palabra por palabra frente a la fuente citada durante nuestra auditoría de fundamentación.
Cálculo
Wang et al. (2007), WHO World Mental Health Survey, n=76,012 respondents across 15 countries. Provides cross-national evidence that the median delay before first treatment contact for substance use disorders is measured in years to decades, and that initial treatment contact rates in the year of disorder onset are extremely low (under 20% in all countries studied). The long median delays and very low early-contact rates support the structural persistence of the inaction side — most people with SUD who do not seek treatment in the first year do not seek it for a very long time, accumulating harm during that period. This source does not supply the 0.52 rate; it quantifies the temporal scale of the inaction.
Advertencias
Ningún lado de esta entrada arrastra una tasa de arrepentimiento directamente validada mediante un instrumento del tipo "¿te arrepientes de esta decisión?". El 0,12 del lado de acción NO es un valor medido: ninguna encuesta nacionalmente representativa reporta la fracción de quienes buscan tratamiento por consumo de sustancias que se arrepienten de haber pedido ayuda, y una versión anterior de esta entrada invirtió incorrectamente una cifra inverificable de "~88% encontró útil el tratamiento" en una tasa de arrepentimiento del 12%. Esa división de utilidad no pudo confirmarse en ninguna tabla accesible de SAMHSA ni en fuente revisada por pares y ha sido eliminada. El 0,12 se conserva solo como un marcador de posición de límite superior transparentemente etiquetado porque el esquema requiere una tasa numérica. Los estudios de satisfacción publicados sobre el tratamiento por consumo de sustancias (cohortes de financiación pública y residenciales) reportan sistemáticamente una satisfacción mayoritaria, por lo que el arrepentimiento-de-acción genuino está casi con certeza muy por debajo de este marcador de posición; el daño derivado de revelar el tratamiento (pérdida de empleo, consecuencias en seguros, daño en relaciones) es real pero afecta a una minoría de quienes buscan tratamiento. El 0,52 del lado de inacción es un proxy de impacto-de-daño: entre los adultos no tratados con trastorno por consumo de sustancias, aproximadamente la mitad declaran que su consumo de sustancias ha afectado negativamente su vida de forma importante. El daño documentado es una condición necesaria pero no suficiente para el arrepentimiento: algunos individuos no enmarcan su consumo de sustancias como una inacción lamentable, y muchos afrontan barreras estructurales (coste, disponibilidad, seguro) que hacen que "buscar tratamiento" sea una elección restringida más que libre. Las cifras de SAMHSA son las estimaciones nacionales oficialmente publicadas de la NSDUH de 2022 (48,7 millones con TUS, de los cuales 13,1 millones recibieron tratamiento por consumo de sustancias —≈27% tratados, ≈73% no tratados); una versión anterior de esta entrada las declaró erróneamente como ~46,8 millones con TUS y ~6,0 millones / 13% tratados, lo que ha sido corregido. Las fuentes accesibles en PMC (revisión de estigma de Hammarlund et al.; encuesta de la OMS de Wang et al.) están revisadas por pares y son plenamente accesibles; las citas textuales están confirmadas. La heterogeneidad poblacional es grande: las tasas de arrepentimiento y los resultados del tratamiento difieren sustancialmente según el tipo de sustancia (alcohol frente a opioides frente a estimulantes), la modalidad de tratamiento (hospitalización frente a ambulatorio frente a asistido con medicación) y las circunstancias individuales. El gilovich_pattern se clasifica como inaction_dominates con base en la señal consistente entre los datos de daño de la NSDUH, la evidencia de retraso del tratamiento de la OMS y la literatura sobre estigma, todas las cuales documentan que los costes de la inacción se acumulan sustancialmente con el tiempo.
